The company's low P/S ratio and poor revenue outlook may be causing its weak share price. Shareholders might be uneasy holding the stock due to the company's potentially less prosperous future. The share price is unlikely to rise significantly soon under these conditions.
雪榕生物股票讨论区
暂无评论